Oncology

Accelerate oncology breakthroughs.

Next-generation therapies bring the promise of better outcomes for cancer patients. But with new discoveries come a more complex development path and more unknowns. We are here to connect your oncology program with solutions to support your success.

Solutions Therapeutics Oncology

Oncology Insights

Your scientific breakthroughs deserve a new approach to development

By making intelligent connections, we bring innovation to the needs of today’s oncology development to help you focus on the patient, manage trial complexity, and increase predictability and speed. IQVIA helps you

Integrate biomarker strategies, operations and partners from development plans through trial execution
Design and execute adaptive and novel trial designs
Use patient insights to improve trial design, speed recruitment and reduce patient burden
Plan and execute cell and gene therapy programs with specialized expertise and resources
Optimize development plans by applying real world and commercial insights in clinical strategies and forecasting scenarios
Apply AI and machine learning to improve trial efficiency and patient safety

11 oncology approvals within 12 months

Oncology market approvals supported by IQVIA, August 2019-2020

LET'S TALK

Early phase oncology

Oncology drug development is moving from drug-centered to patient-centered. From dose escalation through dose optimization, IQVIA’s teams are here to help you navigate the evolving landscape and make informed decisions quickly.

690+ Phase I-II studies since 2016
Dedicated clinical and operational experts for trial design strategy and execution
Technology solutions for enhanced cohort planning and management
Established global network of qualified Phase I oncology sites working in close alignment for fast site activation and better patient recruitment
Modeling and simulation of multiple datasets to identify optimal dose of targeted therapies
End to end laboratory services from Q² Solutions for biomarker services, assay validation and development of companion diagnostics

IQVIA's Oncology Insights Center

Discover the latest topics, trends and scientific developments that are relevant to your oncology program. Read white papers, articles, webinars and more.

explore

Cell and Gene Therapy

Drive cell and gene advanced therapy development from candidate identification through market authorization.

Learn More

Leverage the power of real world data

Through advanced analytics, such as artificial intelligence and machine learning, coupled with our oncology expertise, IQVIA Oncology Commercial Solutions can help track the impact of clinical advancements in real world diagnosis and treatment patterns. By accelerating time to insights we help customers drive business decisions which, ultimately, impact patient care.

The Use of Medicines in the U.S. 2023

Evidence-based research and dissemination of findings remain a key foundation to advance our collective understanding and interpretation of events, and to take actions that will shape the future for all stakeholders. This annual trend report is intended to contribute to that understanding.

learn more

Global Oncology Trends 2022

This annual trend report on Global Oncology from the IQVIA Institute examines those novel medicines and the clusters of research which promise a continuing sequence of breakthroughs in the decade to come. The report explores the impact of COVID-19 disruptions and the longer-term trends in the use of cancer medicines as well as the drivers of spending globally, in key geographies, by tumor type, and for specific types of oncology drugs.

Learn more

Lung Cancer Won't Wait

This report looks at how cancer screening and diagnostic services were affected around the world and considers some of the actions that have been taken to tackle the difficulties – and the promise they hold for future efforts.

Learn more

Oncology

Accelerate oncology breakthroughs.